Skip to content

WAAROOST

Active
Public limited companyfounded 198442 years activeKortrijksestraat 396, 396A, 8020 Oostkamp, BelgiumKBO/BCE: BE 0426.154.850
Summary

WAAROOST has been active since 1984 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.9m and a net result of €703,867. Equity remains stable across the filed fiscal years (±1.4% per year). Its solvency ranks better than 42% of 9,638 sector peers (NACE 46, fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€5.4mtotal assets 2025
Staff
5.4 FTE
Equity
€1.9m
Profit
€703,867
Turnover not published (abridged schema)
Financial health
93 Excellent Checked score 2025
Bankruptcy probability, 12 months
0.1%
Structure
Parent
AEGIDIUS · 99.93%
Accounts 51 days early0 of 13 deeds read
Why 93- Liquidity: current ratio 1.56, cash €408,625, halved+ Founded in 1984+ Size: 5.4 FTE, total assets €5.4m+ Figures for FY 2025 (filed 10-06-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 45% of its sector peers (NACE 46, micro)
Financial strength · tick = 2024
Average
Solvency 61-9
equity 36.0% of total assets
Liquidity 26-35
short-term debt 62.8% · cash 7.5%
Profitability 85-1
return on assets 13.0%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,860 companies)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: 0.1%▲ +0.1 percentage points vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: < 0.1%▼ -0.1 percentage points vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026highest value 08-2026: 0.1%● unchanged vs 07-2026highest value 09-2026: 0.1%● unchanged vs 08-2026highest value 10-2026: 0.1%● unchanged vs 09-2026highest value
Credit up to €180,000 at 30 days acceptable
Liquidity ample (current ratio 1.56 against 1.83 in 2024; short-term debt: 62.8% and cash: 7.5% of total assets), but 64% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 45% on solvency, 24% on liquidity, 80% on profitability and 30% on growth.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
lowers risk · Founded in 1984
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
lowers risk · Size: 5.4 FTE, total assets €5.4m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Liquidity: current ratio 1.56, cash €408,625, halved
NBB · annual accounts
lowers risk · Figures for FY 2025 (filed 10-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-06-2026, 51 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
51 days early
2024
44 days early
2024
63 days early
2023
1 day early
2022
on the day
2021
47 days early
2020
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 30 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
07-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Annual accounts filedfiscal year 2024 · abbreviated…
  3. Annual accounts filedfiscal year 2024 · abbreviated…

Key points

  • Positive: Among the best 5% on net resultsector median €27,371 · 9,615 companies €703,867 View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €703,867 8 years View
  • Controlled by AEGIDIUSultimately: De Sasmeester 99.93% View

By topic

Financials

Fiscal year
2025
Total assets
€5.4m
Profit
€703,867
Solvency
36.0%
Total assets▲ 19.2%
Net result
20192025
Go to Financials

Timeline

Events
12
Since
2018
Next accounts
by 31-07-2027
  1. 30-06-2024Highest result since 2019
  2. 30-06-2024Equity above €10m
  3. 30-01-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
30-08-1984
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.